VWF antibody (AA 1815-1939)
Quick Overview for VWF antibody (AA 1815-1939) (ABIN4949944)
Target
See all VWF AntibodiesReactivity
Host
Clonality
Conjugate
Application
Grade
Clone
-
-
Binding Specificity
- AA 1815-1939
-
Purpose
- vWF Antibody (azide and preservative free)
-
Purification
- Protein G affinity chromatography
-
Immunogen
- Amino acids 1815-1939 from the human protein were used as the immunogen for this vWF antibody.
-
Isotype
- IgG2b, kappa
-
-
-
-
Application Notes
- The optimal dilution of the vWF antibody for each application should be determined by the researcher.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
-
Preservative
- Azide free
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store the vWF antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
-
-
- VWF (Von Willebrand Factor (VWF))
-
Alternative Name
- vWF
-
Background
- Von Willebrand Factor (vWF) is a multimeric glycoprotein that is found in endothelial cells, plasma and platelets. It acts as a carrier protein for Factor VIII and promotes platelet adhesion and aggregation. vWF undergoes a variety of posttranslational modifications that influence the affinity and availability for Factor VIII, including cleavage of the propeptide and formation of N-terminal disulfide bonds. This antibody helps to establish the endothelial nature of some lesions of disputed histogenesis, e.g. Kaposi's sarcoma and cardiac myxoma. It is widely used for differentiating vascular lesions from those of other tissue differentiation within a panel of other vascular markers although not all tumors of endothelial differentiation contain this antigen.
-
UniProt
- P04275
Target
-